iShares AAA CLO ETF [CLOA] vs Adagene [ADAG] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: iShares AAA CLO ETF wins in 9 metrics, Adagene Inc. wins in 2 metrics, with 1 ties. iShares AAA CLO ETF appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | iShares AAA CLO ETF | Adagene Inc. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 741.07 | N/A | N/A |
| Price-to-Book Ratio | 17.24 | 4.95 | Adagene Inc. |
| Debt-to-Equity Ratio | 2.20 | 12.07 | iShares AAA CLO ETF |
| PEG Ratio | N/A | -7.10 | N/A |
| EV/EBITDA | 39.37 | -7.89 | iShares AAA CLO ETF |
| Profit Margin (TTM) | 34.84% | -229.56% | iShares AAA CLO ETF |
| Operating Margin (TTM) | N/A | -74.96% | N/A |
| Return on Equity | 3.16% | -34.39% | iShares AAA CLO ETF |
| Return on Assets (TTM) | 0.88% | -16.00% | iShares AAA CLO ETF |
| Free Cash Flow (TTM) | N/A | $-15.67M | N/A |
| Dividend Yield | 5.21% | N/A | N/A |
| 1-Year Return | 0.04% | 83.08% | Adagene Inc. |
| Price-to-Sales Ratio (TTM) | 0.00 | 31.78 | Tie |
| Enterprise Value | $70.22B | $165.63M | iShares AAA CLO ETF |
| EV/Revenue Ratio | 6.55 | 21.59 | iShares AAA CLO ETF |
| Gross Profit Margin (TTM) | 43.98% | N/A | N/A |
| Revenue per Share (TTM) | $1 | $0 | iShares AAA CLO ETF |
| Earnings per Share (Diluted) | $0.07 | $-0.37 | iShares AAA CLO ETF |
| Beta (Stock Volatility) | N/A | 0.59 | N/A |
| Short % of Float | N/A | 0.19% | N/A |
iShares AAA CLO ETF vs Adagene Inc. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| iShares AAA CLO ETF | 0.01% | 0.04% | -0.08% | 0.31% | 0.17% | 0.19% |
| Adagene Inc. | 0.28% | -8.88% | -9.80% | -9.57% | 91.98% | 95.11% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| iShares AAA CLO ETF | 0.04% | 2.19% | 27,194.74% | 27,194.74% | 27,194.74% | 27,194.74% |
| Adagene Inc. | 83.08% | 178.91% | -74.50% | -87.09% | -87.09% | -87.09% |
Performance & Financial Health Analysis: iShares AAA CLO ETF vs Adagene Inc.
| Metric | CLOA | ADAG |
|---|---|---|
| Market Information | ||
| Market Cap | $0 | $243.81M |
| Market Cap Category | Micro cap | Micro cap |
| 10 Day Avg. Volume | 515,470 | 283,167 |
| 90 Day Avg. Volume | 793,280 | 305,132 |
| Last Close | $51.87 | $3.59 |
| 52 Week Range | $51.53 - $52.05 | $1.30 - $4.85 |
| % from 52W High | -0.36% | -25.98% |
| All-Time High | $52.12 (Dec 02, 2024) | $31.83 (Feb 08, 2021) |
| % from All-Time High | -0.48% | -88.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.15% | 73.33% |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.35% | -2.30% |
| Operating Margin (TTM) | N/A | -0.75% |
| Return on Equity (TTM) | 0.03% | -0.34% |
| Debt to Equity (MRQ) | 2.20 | 12.07 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $2.27 | $0.75 |
| Cash per Share (MRQ) | N/A | $1.28 |
| Operating Cash Flow (TTM) | $3.43B | $-15,657,450 |
| Levered Free Cash Flow (TTM) | $1.01B | $-10,250,600 |
| Dividends | ||
| Last 12-Month Dividend Yield | 5.21% | N/A |
| Last 12-Month Dividend | $2.69 | N/A |
Valuation & Enterprise Metrics Analysis: iShares AAA CLO ETF vs Adagene Inc.
| Metric | CLOA (Apr 24, 2026) | ADAG (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 741.07 | N/A |
| Forward P/E | N/A | -7.10 |
| PEG Ratio | N/A | -7.10 |
| Price to Sales (TTM) | 0.00 | 31.78 |
| Price to Book (MRQ) | 17.24 | 4.95 |
| Market Capitalization | ||
| Market Capitalization | $0 | $243.81M |
| Enterprise Value | $70.22B | $165.63M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 6.55 | 21.59 |
| Enterprise to EBITDA | 39.37 | -7.89 |
| Risk & Other Metrics | ||
| Beta | N/A | 0.59 |
| Book Value per Share (MRQ) | $2.27 | $0.75 |
Financial Statements Comparison: iShares AAA CLO ETF vs Adagene Inc.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | CLOA | ADAG (2025) |
|---|---|---|
| Revenue/Sales | N/A | 7.67M |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | - | 0.0% |
| Gross Profit | N/A | N/A |
| Gross Margin | - | 0.0% |
| Research & Development | N/A | 22.03M |
| Operating Income (EBIT) | N/A | -21.44M |
| Operating Margin | - | -279.5% |
| EBITDA | N/A | -18.22M |
| EBITDA Margin | - | -237.5% |
| Pre-Tax Income | N/A | -17.91M |
| Pre-Tax Income % of Revenue | - | -233.4% |
| Income Tax | N/A | -297,860 |
| Income Tax % of Revenue | - | -3.9% |
| Net Income (Profit) | N/A | -17.61M |
| Profit Margin | - | -229.6% |
Balance Sheet & Liquidity Metrics
| Metric | CLOA | ADAG (2025) |
|---|---|---|
| Cash & Equivalents | N/A | 74.52M |
| Total Current Assets | N/A | 77.38M |
| Total Current Assets % of Revenue | - | 1,008.7% |
| Total Current Liabilities | N/A | 25.17M |
| Total Current Liabilities % of Revenue | - | 328.2% |
| Long-Term Debt | N/A | 1.19M |
| Long-Term Debt % of Revenue | - | 15.5% |
| Total Shareholders Equity | N/A | 35.35M |
| Retained Earnings | N/A | -328.79M |
| Retained Earnings % of Revenue | - | -4,286.1% |
| Property, Plant & Equipment | N/A | 1.82M |
Cash Flow Statement Comparison
| Metric | CLOA | ADAG (2025) |
|---|---|---|
| Operating Cash Flow | N/A | -11.52M |
| Operating Cash Flow % of Revenue | - | -150.1% |
| Capital Expenditures | N/A | -15,653 |
| Free Cash Flow | N/A | -15.67M |
| FCF Margin | - | -204.3% |
| Debt Repayment | N/A | -17.88M |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | CLOA | ADAG |
|---|---|---|
| Shares Short | N/A | 71,244 |
| Short Ratio | N/A | 0.34 |
| Short % of Float | N/A | 0.19% |
| Shares Outstanding | 14.43B | 59.23M |
| Float Shares | N/A | 41.42M |
| % Held by Insiders | N/A | 11.07% |
| % Held by Institutions | N/A | 20.50% |
| % Held by Public | N/A | 68.43% |
Dividend Analysis & Yield Comparison: iShares AAA CLO ETF vs Adagene Inc.
| Metric | CLOA | ADAG |
|---|---|---|
| Last 12-Month Dividend | $2.69 | N/A |
| Last 12-Month Dividend Yield | 5.21% | N/A |
| 3-Year Avg Annual Dividend | $2.97 | N/A |
| 3-Year Avg Dividend Yield | 0.48% | N/A |
| 3-Year Total Dividends | $8.91 | N/A |
| Ex-Dividend Date | Mar 02, 2026 | N/A |